×
About 13,625 results

ALLMedicine™ Adenovirus Center

Research & Reviews  5,076 results

Variability in non-core vaccination rates of dogs and cats in veterinary clinics across...
https://doi.org/10.1016/j.vaccine.2022.01.003
Vaccine Malter KB, Tugel ME et. al.

Jan 18th, 2022 - Vaccination guidelines for dogs and cats indicate that core vaccines (for dogs, rabies, distemper, adenovirus, parvovirus; for cats, feline parvovirus, herpes virus-1, calicivirus) are essential to maintain health, and that non-core vaccines be ad...

Acute kidney injury due to ammonium acid urate stones in a patient with adenovirus gast...
https://doi.org/10.1186/s12894-022-00954-4 10.1007/s00467-004-1675-x 10.5414/CNP73398 10.24953/turkjped.2018.06.025 10.1016/S0022-5347(17)59130-2 10.1055/s-0036-1584923 10.1128/jcm.20.3.365-372.1984 10.5414/CN107098 10.1111/j.1442-2042.2006.01348.x 10.1016/S0022-5347(01)61794-4 10.1111/ped.12626 10.1007/s00467-011-2003-x 10.1007/s00467-010-1607-x 10.1002/ccr3.952
BMC Urology; Ban H, Miura K et. al.

Jan 17th, 2022 - Adenovirus gastroenteritis is a common cause of diarrhea and vomiting in infants, resulting in prerenal acute kidney injury (AKI). However, postrenal AKI due to urinary stones associated with adenovirus gastroenteritis is extremely rare. Here, we ...

GDF11 alleviates neointimal hyperplasia in a rat model of artery injury by regulating e...
https://doi.org/10.1186/s12967-022-03229-6 10.1093/cvr/cvab074 10.1161/JAHA.117.006593
Journal of Translational Medicine; Li L, Gao Y et. al.

Jan 17th, 2022 - Neointimal hyperplasia induced by interventional surgery can lead to progressive obliteration of the vascular lumen, which has become a major factor affecting prognosis. The rate of re-endothelialization is known to be inversely related to neointi...

Novel group C oncolytic adenoviruses carrying a microRNA inhibitor demonstrate enhanced...
https://doi.org/10.1158/1535-7163.MCT-21-0240
Molecular Cancer Therapeutics; Doerner J, Sallard E et. al.

Jan 15th, 2022 - Oncolytic adenoviruses (OAds) represent an attractive treatment option for cancer. Clinical efficacy of commonly utilized human Ad type 5 (Ad5) based oncolytic viruses is limited by variable expression levels of the coxsackie- and adenovirus recep...

see more →

Guidelines  1 results

Community acquired respiratory virus infections in cancer patients-Guideline on diagnos...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125955
European Journal of Cancer (Oxford, England : 1990); von Lilienfeld-Toal M, Berger A et. al.

Sep 30th, 2016 - Community acquired viruses (CRVs) may cause severe disease in cancer patients. Thus, efforts should be made to diagnose CRV rapidly and manage CRV infections accordingly. A panel of 18 clinicians from the Infectious Diseases Working Party of the G...

see more →

Drugs  12 results see all →

Clinicaltrials.gov  127 results

Immunogenicity & Safety Study of Adenovirus Type 5 (AD5) Based Oral Norovirus Vaccines
https://clinicaltrials.gov/ct2/show/NCT04875676

Jan 12th, 2022 - To evaluate the immunogenicity of VXA-G1.1-NN with repeat-dose administration at Day 1 and varying boost schedules (Week 4, 8 or 12 post initial dose) in healthy adults aged 18-55, inclusive, and to assess the safety and tolerability of VXA- G1.1-...

Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation
https://clinicaltrials.gov/ct2/show/NCT05179057

Jan 5th, 2022 - During the period of immune recovery after allogeneic hematopoietic cell transplant (allo-HCT), viral infections and reactivations, including those with AdV, are an important cause of morbidity and mortality. Progression to AdV disease is associat...

A Study of 2-dose Vaccine Regimen Using 3 Consecutive Lots of Ad26.ZEBOV and MVA-BN-Filo in Adult Participants
https://clinicaltrials.gov/ct2/show/NCT04228783

Dec 22nd, 2021 - The purpose of this study is to demonstrate that the paired 2-dose vaccine regimens from 3 consecutively manufactured lots of Adenovirus serotype 26 encoding the Ebola virus Mayinga glycoprotein (Ad26.ZEBOV) as Dose 1 and 3 consecutively manufactu...

Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)
https://clinicaltrials.gov/ct2/show/NCT04760730

Dec 20th, 2021 - This is a prospective, single blinded randomised clinical study, designed to provide data on the heterologous prime boost use of AZD1222 and rAd26-S, to be administered one after the other interchangeably. This study aims to explore the immunogeni...

Efficacy of Different COVID-19 Vaccine Combinations in Inducing Long-term Humoral Immunity [PRIBIVAC]
https://clinicaltrials.gov/ct2/show/NCT05142319

Dec 2nd, 2021 - ICOVID-19 vaccination programs worldwide have so far focused on raising population immunity through the primary COVID-19 vaccine series. In Singapore two mRNA vaccines developed by Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273), have been gran...

see more →

News  231 results

CDC Staff: One mRNA Dose Better Than J&J, Even Among Elusive Patients
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/96276

Dec 17th, 2021 - Clinicians should not automatically give the Johnson & Johnson COVID-19 vaccine even if they suspect patients will not return for a second dose of mRNA vaccine, CDC staff said on a call with clinicians on Friday. CDC's Advisory Committee on Immuni...

J&J's COVID Vaccine on the Way Out?
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/96244

Dec 16th, 2021 - Pfizer and Moderna's COVID-19 vaccines are recommended over Johnson & Johnson's for all adults, the CDC's Advisory Committee on Immunization Practices (ACIP) said on Thursday. The ACIP voted 15-0 that either of the two mRNA vaccines are preferred ...

CDC Panel Backs mRNA COVID Vaccines Over J&J Due to Rare Clot Risk
https://www.medscape.com/viewarticle/964998

Dec 16th, 2021 -  Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A panel of vaccine experts that advises the Centers for Disease Control and Prevention (CDC) on the use of vaccines in the United States said the...

Small Myocarditis Risk Now Seen for Adenovirus-based COVID-19 Vaccine
https://www.medscape.com/viewarticle/965000

Dec 16th, 2021 - The first large population study to investigate the association between different COVID-19 vaccines types and cardiac effects and adverse events shows a small increase in the risk for acute myocarditis with both the mRNA-based vaccines and — in wh...

FDA Updates Risks, Cautions for Clotting-Bleeding Disorder on Janssen COVID-19 Vaccine
https://www.medscape.com/viewarticle/964901

Dec 15th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Updated Janssen/Johnson & Johnson COVID-19 vaccine fact sheets for healthcare professionals and the general public now include a contraindication ...

see more →

Patient Education  3 results see all →